Regulation of glucose transport in cultured muscle cells by novel hypoglycemic agents.

[1]  R. Pollet,et al.  Regulation of glucose transport by pioglitazone in cultured muscle cells. , 1994, Metabolism: clinical and experimental.

[2]  S. Weinstein,et al.  Effects of thiazolidinediones on glucocorticoid-induced insulin resistance and GLUT4 glucose transporter expression in rat skeletal muscle. , 1993, Metabolism: clinical and experimental.

[3]  C. Hofmann,et al.  The antidiabetic agent pioglitazone increases expression of glucose transporters in 3T3-F442A cells by increasing messenger ribonucleic acid transcript stability. , 1993, Endocrinology.

[4]  Y. Mitsumoto,et al.  Hormonal regulation of glucose transporters in muscle cells in culture , 1993, Journal of endocrinological investigation.

[5]  A. Marette,et al.  Insulin Induces the Translocation of GLUT4 From a Unique Intracellular Organelle to Transverse Tubules in Rat Skeletal Muscle , 1992, Diabetes.

[6]  A. Baron,et al.  Gene Expression of GLUT4 in Skeletal Muscle From Insulin-Resistant Patients With Obesity, IGT, GDM, and NIDDM , 1992, Diabetes.

[7]  Y. Mitsumoto,et al.  Development regulation of the subcellular distribution and glycosylation of GLUT1 and GLUT4 glucose transporters during myogenesis of L6 muscle cells. , 1992, The Journal of biological chemistry.

[8]  Garvey Wt.  Glucose Transport and NIDDM , 1992 .

[9]  R. Ulrich,et al.  Enhancement of adipocyte differentiation by an insulin-sensitizing agent. , 1992, Molecular pharmacology.

[10]  J. Olefsky,et al.  Metabolic Effects of New Oral Hypoglycemic Agent CS-045 in NIDDM Subjects , 1992, Diabetes Care.

[11]  R. DeFronzo,et al.  Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects. , 1991, The Journal of clinical endocrinology and metabolism.

[12]  K. Lorenz,et al.  Glucose transport deficiency in diabetic animals is corrected by treatment with the oral antihyperglycemic agent pioglitazone. , 1991, Endocrinology.

[13]  M. Laakso,et al.  Reduced capacity and affinity of skeletal muscle for insulin-mediated glucose uptake in noninsulin-dependent diabetic subjects. Effects of insulin therapy. , 1991, The Journal of clinical investigation.

[14]  C. Carter-Su,et al.  Adipose Tissue Glucose Transporters in NIDDM: Decreased Levels of Muscle/Fat Isoform , 1991, Diabetes.

[15]  Y. Mitsumoto,et al.  Differential expression of the GLUT1 and GLUT4 glucose transporters during differentiation of L6 muscle cells. , 1991, Biochemical and biophysical research communications.

[16]  M. Birnbaum,et al.  Pretranslational suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin-dependent diabetes mellitus and obesity. , 1991, The Journal of clinical investigation.

[17]  R. McPherson,et al.  Actions of Novel Antidiabetic Agent Englitazone in Hyperglycemic Hyperinsulinemic ob/ob Mice , 1990, Diabetes.

[18]  K. Heidenreich,et al.  In vitro studies on the action of CS-045, a new antidiabetic agent. , 1990, Metabolism: clinical and experimental.

[19]  J. Flier,et al.  Evidence Against Altered Expression of GLUT1 or GLUT4 in Skeletal Muscle of Patients With Obesity or NIDDM , 1990, Diabetes.

[20]  H. Lodish,et al.  Molecular Physiology of Glucose Transporters , 1990, Diabetes Care.

[21]  A. Klip,et al.  Glucose transport activity in L6 muscle cells is regulated by the coordinate control of subcellular glucose transporter distribution, biosynthesis, and mRNA transcription. , 1990, The Journal of biological chemistry.

[22]  E. Horton,et al.  Identification of an intracellular pool of glucose transporters from basal and insulin-stimulated rat skeletal muscle. , 1990, The Journal of biological chemistry.

[23]  C. Bailey,et al.  New antidiabetic drugs , 1990 .

[24]  M. Birnbaum,et al.  The acquisition of increased insulin-responsive hexose transport in 3T3-L1 adipocytes correlates with expression of a novel transporter gene. , 1989, The Journal of biological chemistry.

[25]  J. Gerich.  Oral hypoglycemic agents. , 1989, The New England journal of medicine.

[26]  A. Baron,et al.  Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans. , 1988, The American journal of physiology.

[27]  T. Fujiwara,et al.  Characterization of New Oral Antidiabetic Agent CS-045: Studies in KK and ob/ob Mice and Zucker Fatty Rats , 1988, Diabetes.

[28]  R. DeFronzo.  The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM , 1988, Diabetes.

[29]  D. James,et al.  Insulin-regulatable tissues express a unique insulin-sensitive glucose transport protein , 1988, Nature.

[30]  G. Bray,et al.  Effect of ciglitazone on glucose uptake and insulin sensitivity in skeletal muscle of the obese (ob/ob) mouse: distinct insulin and glucocorticoid effects. , 1986, Metabolism: clinical and experimental.

[31]  A. Klip,et al.  Induction of sugar uptake response to insulin by serum depletion in fusing L6 myoblasts. , 1984, The American journal of physiology.

[32]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[33]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.